Vidon

Follow us
  • Twitter
  • Linkedin
  • Rss

Log in or Sign up

  • Français (FR)
  • English (UK)

PiVisu®

  • GROUP
    • Word of the founding partner
    • Presentation
    • Our values
  • OFFICES
    • PARIS
    • RENNES
    • NANTES
    • CAEN
    • ROSCOFF
    • SAINT MALO
    • MUNICH
    • BANGKOK
    • SHANGHAÏ
    • HONG KONG
  • TEAMS
    • Management & consultants
    • Patents
    • Trademarks
    • Support services
  • SERVICES
    • AREAS OF PRACTICE
      • Audit IP
      • Contracts
      • Copyright
      • Designs
      • Internet domain names
      • Strategic support of defence - litigation
      • Patents
      • Pivalua ® - valorisation & optimization
      • Securisation of evidences
      • Trademarks
      • Watching & monitoring
    • EXPERTISE
      • Innojuris ® - Training & awarness action
      • Investigation
      • IP vulnerability diagnostic
      • Know-how protection
      • Lucta ® - strategic supports fighting against counterfeiting
      • Management of cooperation
      • Patent Mapping
      • Pivalua ® - valorisation & optimization
      • PiVisu ® - IP portfolio management
      • Strategic support of defence - litigation
      • Strategic support of protection
      • Taya ® - protection of concepts
      • Trademark translitteration
      • Watching & monitoring
  • NEWS
  • CAREERS
  • CONTACT
  • VIDON

    VIDON

  • Offices

    Offices

    Vidon Europ Vidon China Vidon Asia

     

Offices

OFFICES

  • EUROPE
    • PARIS
    • RENNES
    • NANTES
    • CAEN
    • ROSCOFF
    • SAINT MALO
    • MUNICH
  • ASIA
    • BANGKOK
    • SHANGHAÏ
    • HONG KONG

Teams

TEAMS

  • Your contacts
  • Management & consultants
  • Patents
  • Trademarks
  • Support services

Services

SERVICES

  • Expertise

    • IP vulnerability diagnostic
    • Lucta ® - strategic supports fighting against counterfeiting
    • Pivalua ® - valorisation & optimization
    Read more ...  
  • Areas of practice

    • Patents
    • Trademarks
    • Designs
    Read more ...  

Careers

CAREERS

Read more

LAST NEWS

See all news

Patrice Vidon appointed judge for UPC (Unifie...

Patrice Vidon appointed judge for UPC (Unified Patent Court)

The Unified Patent Court* confirmed the appointment of 85 judges to take up their duties as of the entry into force of the UPC Agreement. Patrice Vidon will join the technically qualified judges for Mechanical…

Readmore...

Changes to the designation of inventors (EPO)...

Changes to the designation of inventors (EPO)

In a press release dated February 22, 2021, the European Patent Office indicates several changes made to Rules 19 and 143 EPC relating to the designation of inventors, taking into account the requirements of the…

Readmore...

Vidon Group keynote Speaker at a EU webinar a...

Vidon Group keynote Speaker at a EU webinar about IPR protection strategies for SMEs in Asia

During a webinar about Intellectual Property Rights in China and ASEAN countries hosted by China and South-East Asia IP SME Helpdesk on May 12, 2021, EARSC (European Association of Remote Sensing Companies) had the opportunity…

Readmore...

Pakistan joins the Madrid System ...

Pakistan joins the Madrid System

    Pakistan joins the Madrid System and can be designated through an International trademark now       www.istockphoto.com The WIPO (World Intellectual Property Organization) just announced the accession of the Pakistan to the…

Readmore...

Introduction of the administrative action for...

Introduction of the administrative action for revocation and invalidity in France

         The current health crisis does not prevent the long-awaited launch of the administrative procedure for invalidity and revocation in France.     The major innovation of the “PACTE” law on trademarks,…

Readmore...

Revision of European Patent Office’s fees w...

Revision of European Patent Office’s fees with effect from 1 April, 2020

The EPO has announced a revision of fees which will enter into force on 1 April 2020. This revision involves main fees (filing fee, search fee, examination fee, grant fee) as well as annual fees.…

Readmore...

Specific exemption: a necessity for pharmaceu...

Specific exemption: a necessity for pharmaceutical trademarks?

Specific exemption: a necessity for pharmaceutical trademarks?Clinical trial, Marketing Authorization Application and genuine use of a trademark.      Should pharmaceutical trademarks benefit of a  specific exemption for demonstrating their genuine use ?    …

Readmore...

VIDON Group supportive of China...

VIDON Group supportive of China

At the beginning of the New Lunar Year of the Rat’s, China is experiencing exceptional health measures. Following the traditional Spring Festival Holidays, the resumption of work was postponed by the authorities to Monday, February…

Readmore...

First sound trademark published by the French...

First sound trademark published by the French Trademark Office !

    First sound trademark published by the French Trademark Office !     Protection of “non-traditional” trademarks is now available in France First measures of the EU Trademark Package’s French transposition are in force since last December…

Readmore...

First Trademark Law in Myanmar...

First Trademark Law in Myanmar

First Trademark Law in Myanmar : Save the Date ! The first Trademark Law in Myanmar has been passed and signed on January 30th, 2019, which implies that the country will have a specific system…

Readmore...

La Société Sauermann, cliente du Groupe Vidon, Lauréat Brevets des Trophées de l’Innovation INPI 2013 – lle de France

La Société Sauermann, qui conçoit et fabrique des pompes de relevage de condensats, a été désignée Lauréat Brevets des Trophées de l’Innovation 2013, pour la région Ile de France, et concourt donc désormais pour le titre au niveau national.

A cette occasion, Monsieur Chauvin, Directeur R&D, a souligné la nécessité de la Propriété Industrielle dans le développement et la pérennité de la Société, et l’importance de la coopération avec ses Conseils en PI pour établir de façon efficace les stratégies de PI adaptées, en lien avec les stratégies de développement de la Société.

Ludovic Bioret était présent, pour féliciter de vive voix le Lauréat. Le Groupe Vidon dans son ensemble félicite à nouveau la Société Sauermann pour cette récompense prestigieuse.

 

E-réputation - Le nouveau service ADULTBLOCK+ (noms de domaine Internet .xxx, .sex, .adult et .porn) se fixe pour objectif de limiter la nuisance de la fin du blocage des .xxx

Ecran Cadena 2020

 

 E-réputation - Le nouveau service ADULTBLOCK+(noms de domaine   Internet .xxx, .sex, .adult et .porn) se fixe pour objectif de limiter la nuisance de la fin du blocage des .xxx

 

Pour se prémunir face à un risque de cybersquatting le .xxx, et les autres extensions du domaine pornographique (.sex, .adult et .porn) qui ont été créés dans l’intervalle, trouvent leur solution avec ADULTBLOCK+ !

Read more ...

Introduction of the administrative action for revocation and invalidity in France

 

 

Sans titre  

 

The current health crisis does not prevent the long-awaited launch of the administrative procedure for invalidity and revocation in France.

 

 

The major innovation of the “PACTE” law on trademarks, came into force on 1 April 2020: with the creation of a "Cancellation" cell within the French Office, it is now possible to bring an action for a declaration of invalidity or revocation in the form of an administrative procedure. 

Read more ...

Revision of European Patent Office’s fees with effect from 1 April, 2020

The EPO has announced a revision of fees which will enter into force on 1 April 2020. This revision involves main fees (filing fee, search fee, examination fee, grant fee) as well as annual fees.

It is possible to arrange advanced payment of fees in the coming weeks (annual fees, examination fee, grant fee) and pay before 31, March 2020 in order to benefit from the current rate.

Feel free to contact us, we are at your disposal to assist you in the management of your patent rights.

 

Specific exemption: a necessity for pharmaceutical trademarks?

Specific exemption: a necessity for pharmaceutical trademarks?
Clinical trial, Marketing Authorization Application and genuine use of a trademark.

Medecin  

 

Should pharmaceutical trademarks benefit of a  specific exemption for demonstrating their genuine use ?

 

 

 

(Copyright free taken from data base pxhere.com)

The Court of Justice of the European Union (CJEU) confronts its traditional case law to the particular frame of pharmaceutical trademarks’ genuine use appreciation.

Traditionally, case law established a relative tolerance to the condition of genuine use since the latter can be recognized for goods and services whose commercialization is not effective yet, but under way (CJEC, Ansul, March 11th, 2003, C-40/01).

Besides, it has already been specified that only obstacles that present a relation sufficiently direct with a trademark making impossible or unreasonable its useand that are independent from the will of the trademark’s owner can be qualified as “proper reasons” for non-use.   

Read more ...

  • Start
  • Prev
  • Next
  • End
  • OFFICES
    • Paris
    • Rennes
    • Nantes
    • Caen
    • Roscoff
    • Saint Malo
    • Munich
    • Bangkok
    • Shanghaï
    • Hong Kong
  • AREAS OF PRACTICE
    • Audit
    • Contracts
    • Copyright
    • Designs
    • Internet domain names
    • Litigation
    • Pivalua ® - valuation & optimization
    • Patents
    • Securisation of evidences
    • Trademarks
    • Watching & monitoring
  • EXPERTISE
    • Investigation
    • IP vulnerability diagnostic
    • Know-how protection
    • Lucta ® - strategic supports fighting against counterfeiting
    • Management of cooperation
    • Mapping
    • Pivalua ® - valuation & optimization
    • PiVisu ® - IP portfolio management
    • Strategic support of defence
    • Strategic support of protection
    • Taya ® - protection of concepts
    • Training & awarness action
    • Trademark translitteration

CUSTOMER ACCOUNT

Forgot your username? Forgot your password?

Or sign in with your account on:

LinkedIn
Not a member yet? Register
  • Twitter
  • Linkedin
  • Rss
  • Vidon © 2013
  • Legal notice
  • webdesign : www.web-ia.com
Top